Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
paclitaxel (taxol) (1 trial)
prs-080 (3 trials)
prs-343 (3 trials)
prs-344 (1 trial)
ramucirumab (cyramza) (1 trial)
tucatinib (Tukysa) (1 trial)
angiocal (1 trial)
atezolizumab (Tecentriq) (1 trial)
elarekibep (2 trials)
prs-220 (1 trial)
Asthma (Phase 1)
Kidney Diseases (Phase 2)
Neoplasms (Phase 1)
Renal Insufficiency, Chronic (Phase 2)
Respiratory Aspiration (Phase 1)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Trials (11 total)
Trial APIs (10 total)